Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Clinical trial NCT02994498 · UNKNOWN

Trial details

NCT number: NCT02994498
Sponsor: Chung Mei Biopharma Co., Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2023-03-01
Primary completion: 2025-09-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.